Research Article
Urinary F2-Isoprostanes and Metabolic Markers of Fat Oxidation
Table 3
Association of the baseline F2-isoprostane index and three selected acylcarnitines with incident type 2 diabetes (114 cases).
| ||||||||||||||||
ORs adjusted for age, gender, ethnicity, clinic and baseline BMI, and IGT-status and scaled to SD of F2-isoprostanes or acylcarnitines (log-transformed). |